Search results for "Diffusion weighted imaging"

showing 5 items of 15 documents

Diffusion-weighted imaging in oncology: An update

2020

To date, diffusion weighted imaging (DWI) is included in routine magnetic resonance imaging (MRI) protocols for several cancers. The real additive role of DWI lies in the “functional” information obtained by probing the free diffusivity of water molecules into intra and inter-cellular spaces that in tumors mainly depend on cellularity. Although DWI has not gained much space in some oncologic scenarios, this non-invasive tool is routinely used in clinical practice and still remains a hot research topic: it has been tested in almost all cancers to differentiate malignant from benign lesions, to distinguish different malignant histotypes or tumor grades, to predict and/or assess treatment resp…

OncologyCancer Researchmedicine.medical_specialtyReviewCancer imaginglcsh:RC254-282030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMagnetic resonance imagingInternal medicinemedicineEffective diffusion coefficientcardiovascular diseasesapparent diffusion coefficient; cancer imaging; diffusion weighted imaging; magnetic resonance imaging; oncologic imagingmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingDiffusion weighted imaginglcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensOncologic imagingClinical PracticeOncologyApparent diffusion coefficient030220 oncology & carcinogenesisCancer imagingbusinessDiffusion MRI
researchProduct

Role of the Apparent Diffusion Coefficient (ADC) values analysis in Diffusion Weighted Imaging (DWI-MR) in the characterization of prostatic disease …

Purpose To evaluate if apparent diffusion coefficient analysis on magnetic resonance imaging can differentiate between normal and pathological prostate tissue, including prostate cancer and precancerous conditions (ASAP and PIN). Materials and Methods Prostate MRI with endorectal coil was performed in 93 patients (mean age 65.4). Regions of interest were placed over suspicious areas, detected on MRI, and over areas with normal appearance, and ADC values were recorded. Statistical differences between ADC values of suspicious and normal areas were evaluated. Histopathological diagnosis, obtained from targeted biopsy in 51 patients and from prostatectomy in 42 patients, were correlated to ADC …

Prostate Diffusion Weighted Imaging Apparent Diffusion Coefficient MRISettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Can histographic analysis of apparent diffusion coefficient help discriminate between benign and malignant nodes in head and neck squamous cell carci…

2011

Objective: To investigate histographic analysis of apparent diffusion coefficient (ADC) measurements as discriminators of benign from malignant lymph nodes in patients with head and neck (H&N) squamous cell carcinoma (SCC) Materials and Methods: Seventeen patients with H&N SCC staged for nodal disease using anatomical MRI, contrast enhanced CT and ultrasound ± fine needle aspiration gave informed consent for additional MR diffusion weighted imaging (DWI). Axial DWI was performed by short tau inversion recovery (STIR) echo planar imaging and trace weighted images obtained b 0, 50, 100, 300, 600 and 1000. Image analysis was conducted using Jim 5.0. Nodal disease and contralateral benign nodal…

Squamocellular carcinoma MRI Diffusion Weighted Imaging Hystographic analysis
researchProduct

Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: What radiologists should know

2016

The technological advances in radiological imaging and the relevance of a diagnostic tool that may reduce radiation-induced long-term effects have led to a widespread use of whole body magnetic resonance imaging (WB-MRI) with diffusion weighted imaging for oncologic patients. A lot of studies demonstrated the feasibility and reliability of WB-MRI as an alternative technique for lymphoma staging and response assessment during and after treatment. In this paper, taking advantage of our 2years of experience using WB-MRI for lymphoma, we discuss the main pitfalls and artifacts radiologists should know examining a WB-MRI performed on this typology of patients in order to avoid images misinterpre…

medicine.medical_specialtyRadiology Nuclear Medicine and ImagingLymphomaWhole body mriBiophysicsBiomedical EngineeringPitfall030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMagnetic resonance imagingRadiologistsHumansMedicineEffective diffusion coefficientWhole Body ImagingMedical physicsDiagnostic ErrorsRadiological imagingmedicine.diagnostic_testbusiness.industryReproducibility of ResultsMagnetic resonance imagingDiffusion weighted imagingmedicine.diseaseOncologic imagingLymphomaResponse assessmentDiffusion Magnetic Resonance ImagingBiophysic030220 oncology & carcinogenesisArtifactClinical CompetenceRadiologyArtifactsbusinessWhole bodySettore MED/36 - Diagnostica Per Immagini E RadioterapiaDiffusion MRI
researchProduct

Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas

2020

The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can noninvasively predict the most common IDH mutational status (R132H) in GIII-astrocytomas and the overall survival (OS). Hence, twenty-two patients (9-F, 13-M) with a histological diagnosis of GIII-astrocytoma and evaluation of IDH-mutation status (12-wild type, 10-mutant) were retrospectively evaluated. Imaging studies were reviewed for the morphological feature and mean ADC values (ADCm). Stati…

medicine.medical_specialtyoverall survivalClinical BiochemistryradiogenomicsRadiogenomicsGastroenterologyArticle03 medical and health sciences0302 clinical medicineGliomaInternal medicinemedicineOverall survivalEffective diffusion coefficientdiffusion weighted imaging (DWI)apparent diffusion coefficient (ADC)lcsh:R5-920medicine.diagnostic_testbusiness.industryanaplastic astrocytomaMagnetic resonance imagingmedicine.diseaseExact testIsocitrate dehydrogenaseisocitrate dehydrogenase (IDH) mutation030220 oncology & carcinogenesisHuman medicinelcsh:Medicine (General)businessanaplastic astrocytomas030217 neurology & neurosurgeryAnaplastic astrocytomaDiagnostics
researchProduct